Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Hubei Jumpcan Pharmaceutical Co Change In Receivables?

Hubei Jumpcan Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Hubei Jumpcan Pharmaceutical Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Hubei Jumpcan Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥23 Mil. It means Hubei Jumpcan Pharmaceutical Co's Accounts Receivable declined by ¥23 Mil from Dec. 2022 to Dec. 2023 .

Hubei Jumpcan Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥1,956 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Hubei Jumpcan Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 74.30.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hubei Jumpcan Pharmaceutical Co's liquidation value for the three months ended in Mar. 2024 was ¥9,442 Mil.

Hubei Jumpcan Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Hubei Jumpcan Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Jumpcan Pharmaceutical Co Change In Receivables Chart

Hubei Jumpcan Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

28.72

15.25

-181.19

-713.70

22.82

Hubei Jumpcan Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Hubei Jumpcan Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hubei Jumpcan Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1956.378	/	2402.546	*	91
=	74.30

2. In Ben Graham's calculation of liquidation value, Hubei Jumpcan Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Hubei Jumpcan Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	12834.786	-	5145.996	+	0.75 * 1956.378	+	0.5 * 571.195
=	9,442

Hubei Jumpcan Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Hubei Jumpcan Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Jumpcan Pharmaceutical Co Ltd (SHSE:600566) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

Heights Garden Road, Room 602 fashion, Shashi District, Jingzhou, Hubei, CHN

Website

http://www.jumpcan.com

Hubei Jumpcan Pharmaceutical Co Ltd engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based on Chinese traditional medicines, and Chinese medicine health products in China. It offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatric. The company also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.

Executives

Cao Wei	Directors, senior managers
Zhou Qi Hua	senior management
Huang Qu Rong	Director
Yan Hong Quan	senior management
Shi Wen Zheng	senior management
Zhang Jian Min	Director
Cao Long Xiang	Director
Yan Yue Hua	Director

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Headlines

No Headlines